Abstract:In this study library of bisubstarte analogues, uridine‐mimetic peptide conjugates are designed, synthesised and evaluated for their O‐linked β‐N‐acetylglucosamine transferase (OGT) inhibition activity. In this approach uridine diphosphate moiety from sugar donor UDP‐GlcNAc is replaced with quinolinone‐6‐sulfonamide (Q6S) or quinolone‐4‐carboxamide (Q4 C). OGT inhibition assay suggested that bisubstarte analogues have retained OGT inhibition and enzyme inhibition is peptide sequence dependent. Our finding demonstrates that replacement of charged nucleotide with quinolinone heterocycles will aid development of cell‐permeable OGT inhibitors in the future. O‐linked β‐N‐acetylglucosamine transferase (OGT) is the pivotal mammalian enzyme that serves as a nutrient sensor, linking metabolic status to diverse cellular signalling pathways by catalyzing N‐acetylglucosamine transfer to various proteins and detects fluctuations in UDP‐GlcNAc concentrations. Increased UDP‐GlcNAc levels induce O‐GlcNAcylation of proteins, influencing the stability and localization of biomolecules, including transcription factors, kinases, phosphatases, tumour suppressors, and histone‐modifying proteins. Dysregulation and excessive OGT expression can adversely impact cellular processes. The lack of potent and selective inhibitors for OGT has impeded the progress in understanding the enzyme and its molecular mechanisms. This research article details the successful development and synthesis of a series of bisubstrate analogue inhibitors, specifically focusing on inhibiting the O‐GlcNAc transferase (OGT) enzyme. Compound 29 emerged as a promising inhibitor, demonstrating an IC50 value of 134.40 μM in in‐vitro assays. The study emphasizes the crucial role of the acceptor substrate analogue in bisubstrate inhibitor design, highlighting its equal importance alongside the donor substrate analogue. While donor substrate mimetics alone exhibited limited inhibition, their conjugation with appropriate peptides significantly enhanced the overall potency of the final bisubstrate inhibitor. Particularly, peptide derivatives proved superior as acceptor substrate analogues compared to normal substrate peptides. Preliminary data suggest the potential of uridine‐mimetics, like Q6S and Q4 C, following scaffold structure refinement. In‐silico predictions propose that replacing pyrophosphate with a flexible linker substantially improves physicochemical properties relevant to cell permeation. This comprehensive investigation offers valuable insights into designing and optimizing bisubstrate analogue inhibitors for OGT, revealing potential avenues for further refinement and development.

Virtual Screening of Human O-Glcnac Transferase Inhibitors

Spatiotemporal Activation of Protein O-GlcNAcylation in Living Cells.

Discovery of a Low Toxicity O-GlcNAc Transferase (OGT) Inhibitor by Structure-based Virtual Screening of Natural Products

Discovery and Activity Verification of a O-GlcNAc Transferase Inhibitor by Structure-based Virtual Screening

Activity Based High-Throughput Screening for Novel O-GlcNAc Transferase Substrates Using a Dynamic Peptide Microarray

Discovery of Cell-Permeable O-GlcNAc Transferase Inhibitors Via Tethering in Situ Click Chemistry.

Elucidating the protein substrate recognition of O-GlcNAc transferase (OGT) toward O-GlcNAcase (OGA) using a GlcNAc electrophilic probe

Discovery of Novel Inhibitors Targeting Human O-GlcNAcase: Docking-Based Virtual Screening, Biological Evaluation, Structural Modification, and Molecular Dynamics Simulation

A DNA Nanoscaffold-Based Electrochemical Assay for Sensitive Determination of O-GlcNAc Transferase (OGT) Activity and Its Application in Cell-Permeable OGT Inhibitors Screening

An Economical High-Throughput "Fp-Tag" Assay for Screening Glycosyltransferase Inhibitors

Discovery of two non-UDP-mimic inhibitors of O-GlcNAc transferase by screening a DNA-encoded library

Discovery of a novel OGT inhibitor through high-throughput screening based on Homogeneous Time-Resolved Fluorescence (HTRF)

OGT As Potential Novel Target: Structure, Function and Inhibitors

Bisubstrate Uridine‐Mimetic‐Peptide Conjugates as O‐GlcNAc Transferase (OGT) Inhibitors

Amino acid tethered benzoxazolone as highly potent inhibitors of O-glycosylation

Elevation of cellular O-GlcNAcylation level by a potent and selective O-GlcNAcase inhibitor based on tetrahydroimidazopyridine scaffold.

New ELISA-based Method for the Detection of O-GlcNAc Transferase Activity in Vitro

A Fluorescence-Based Microplate Assay for High-Throughput Screening and Evaluation of Human UGT Inhibitors.

Identification of Novel Inhibitors Targeting SGK1 via Ensemble-Based Virtual Screening Method, Biological Evaluation and Molecular Dynamics Simulation

Discovery of Geranylgeranyltransferase-I Inhibitors with Novel Scaffolds by the Means of Quantitative Structure-Activity Relationship Modeling, Virtual Screening, and Experimental Validation

Virtual screening, identification and in vitro validation of small molecule GDP-mannose dehydrogenase inhibitors